Cargando…
Pembrolizumab-Induced Immune-Mediated Hepatitis and Concurrent Hepatitis B Reactivation in a Patient With Non-Small Cell Lung Cancer
New immuno-therapeutic agents like pembrolizumab used in cancer treatment are known to cause immune-mediated hepatitis. Most of these cases are straightforward when the onset of transaminitis correlates with the introduction of the medication. This agent causing hepatitis B reactivation has been rep...
Autores principales: | Kundumadam, Shanker, Mohamad, Bashar, Muthusamy, Arun, Kathi, Pradeep R, Ehrinpreis, Murray N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746005/ https://www.ncbi.nlm.nih.gov/pubmed/33354466 http://dx.doi.org/10.7759/cureus.11522 |
Ejemplares similares
-
Acute Gastrointestinal Bleeding Due to Cytomegalovirus Colitis in a Patient with Common Variable Immunodeficiency
por: Kathi, Pradeep, et al.
Publicado: (2018) -
Hemophagocytic Syndrome-Like Tuberculosis-Immune Reconstitution Inflammatory Syndrome After the Initiation of Hepatic Tuberculosis Treatment
por: Nakamura, Serina, et al.
Publicado: (2022) -
Hyperhemolytic Crisis Following Transfusion in Sickle Cell Disease With Acute Hepatic Crisis: A Case Report
por: Trivedi, Krunal, et al.
Publicado: (2022) -
Metastatic Mucinous Adenocarcinoma of the Cervix Presenting as Acute Hepatitis
por: Kundumadam, Shanker, et al.
Publicado: (2020) -
An Unusual Case of Recurrent Hypersensitivity Reaction Associated with Kounis-Like Acute Coronary Syndrome
por: Kundumadam, Shanker, et al.
Publicado: (2017)